Brian Hess to Cell- and Tissue-Based Therapy
This is a "connection" page, showing publications Brian Hess has written about Cell- and Tissue-Based Therapy.
Connection Strength
0.314
-
Gastric adenocarcinoma following CD19-directed chimeric antigen receptor T cell therapy. Ann Hematol. 2023 02; 102(2):461-462.
Score: 0.210
-
Fever Characteristics and Impact on Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy. Clin Lymphoma Myeloma Leuk. 2023 01; 23(1):e14-e18.
Score: 0.052
-
Real-World Experience and Optimization of Outpatient Chimeric Antigen Receptor T Cell Therapy. Transplant Cell Ther. 2022 09; 28(9):583-585.
Score: 0.051